Shares of Retrophin fell 27% after its rare disease drug candidate failed to work better than a placebo in a late-stage clinical study.
The California Life Sciences Association on Aug. 20 announced that it added nine board members, including from Amgen, DuPont Nutrition & Biosciences and Ernst & Young.
A postoperative pain anesthetic from Heron Therapeutics reduced pain intensity and the use of opioids among hernia surgery patients in a late-stage clinical trial, the company reported Aug. 20.
A professor at Sanford Burnham Prebys Medical Discovery Institute landed a $4.96 million grant to further study a preclinical program for oxygen-deprived newborns at risk of neurological disorders.
BIOTECH: CEO Irwin Is Out; CFO Jackson Named Interim Leader
Amid legal, manufacturing and financial problems Ra Medical Systems delayed the release of second quarter results.
In a July letter to insurers the California Department of Managed Care, or CDMC, fired a warning shot against association health plans, in what could have wide-reaching impacts for biotechs, life sciences trade groups and other industries.
PROPERTY: Execs’ Offices Take Back Seat to Workers’
Give the best views of the ocean and surrounding landscape to the researchers up front.
Lineage Underwent Corporate Restructuring, Co. to Focus on 3 Programs
BioTime is getting a new name — and a new headquarters.
Shelley Lyford, the CEO of the nonprofit West Health, has been appointed to California’s Master Plan for Aging Stakeholder Advisory Committee.
Virtual Care Opens Lines Of Communication, Healing
Telemedicine is by no means new. But lagging insurance coverage and infrastructure costs prevented wide adoption. That’s changing,
Ionis Having Good Discussions With FDA on Other Therapeutic
Ionis Pharmaceuticals’ drug for a muscle-wasting disease continues to be the company’s main driver of growth, with competition looming.
Amid legal, manufacturing and financial challenges Ra Medical Systems delayed the release of second quarter results and fired its CEO.
A $59 million cancer center on the campus of Scripps Mercy Hospital that’s geared toward the central and southern parts of San Diego recently broke ground.
Expansions By Some Of the Bigger Players Are Expected in Q3
The leasing footprint of San Diego life sciences companies grew by 263,399 square feet in the second quarter, according to report from the brokerage firm JLL.
San Diego-based Halozyme reported $39.1 million in second quarter revenue, an 11% year-over-year increase.